ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryAllschwilBasilea Pharmaceutica AG, Allschwil
Basilea Pharmaceutica AG, Allschwil Logo
Verified· 4 sourcesTrust Score
Summary

About the company

Basilea Pharmaceutica AG, Allschwil is a pharmaceutical company that develops and commercializes medicines for severe and life‑threatening bacterial and fungal infections. Its portfolio includes antifungal and antibacterial products such as Cresemba (isavuconazole) and Zevtera.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Basilea Pharmaceutica AG, Allschwil

5
Development and commercialization of anti-infectives
Development and commercialization of innovative medicines in the field of anti-infectives, focusing on antifungals and antibiotics for severe infections.
Antifungal Cresemba
Intravenous and oral antifungal with Isavuconazol for the treatment of invasive aspergillosis and mucormycosis; distributed worldwide via partners.
Antibiotic Zevtera
Intravenous antibiotic with Ceftobiprole for the treatment of pneumonia, Staphylococcus aureus bacteremia, acute skin infections, and community-acquired bacterial pneumonia.
Antifungal drug candidates
Clinical antifungal candidates such as Fosmanogepix and BAL2062 for candidemia, invasive candidiasis, and invasive mould infections.
Antibiotic drug candidates
Clinical antibiotic programs such as Ceftibuten-ledaborbactam etzadroxil and BAL2420 for complicated urinary tract infections and gram-negative, multi-drug resistant bacteria.
Trust & reputation

ranQ Trust Score of Basilea Pharmaceutica AG, Allschwil: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 100% · As of October 2026

Basilea Pharmaceutica AG, Allschwil scores 59.6 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.66.724%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.27.910%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.78.08%
Basilea Pharmaceutica AG, Allschwil scores 95.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.96.07%
Basilea Pharmaceutica AG, Allschwil scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Basilea Pharmaceutica AG, Allschwil scores 50.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.0.04%
Qualifications+0.00

Basilea Pharmaceutica AG, Allschwil reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». The rating draws, among other things, on 4.5 out of 5 stars from 2 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
4.5
of 5

Aggregated from 2 reviews across all connected sources

Sources
GGoogle4.52
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

March 26, 2026Media
Basilea, sales projected to triple
agefi.com
March 26, 2026Media
Basilea erwartet eine Verdreifachung des Umsatzes
agefi.com

Knowledge

No knowledge articles yet

Once Basilea Pharmaceutica AG, Allschwil has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Basilea Pharmaceutica AG, Allschwil in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Basilea Pharmaceutica AG, Allschwil by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Basilea Pharmaceutica AG, Allschwil to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hegenheimermattweg 167b
4123 Allschwil
Opening hours
Mon
08:00 - 12:00, 13:00 - 17:00
Tue
08:00 - 12:00, 13:00 - 17:00
Wed
08:00 - 12:00, 13:00 - 17:00
Thu
08:00 - 12:00, 13:00 - 17:00
Fri
08:00 - 12:00, 13:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-101.175.068
Founded
2002 · 24 years
Last commercial register change
May 7, 2026
Employees
101 to 500
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    MG
    MiHKAL GmbH
    Allschwil
    NS
    Neurocrine Switzerland GmbH
    Allschwil
    CT
    CAPTOR THERAPEUTICS GmbH
    Allschwil
    GG
    Gubra GmbH
    Allschwil
    TP
    T3 Pharmaceuticals AG
    Allschwil
    AT
    Alentis Therapeutics AG
    Allschwil
    BP
    Bright Peak Therapeutics AG
    Allschwil
    CP
    Corden Pharma Fribourg AG, Zweigniederlassung Ettingen
    Ettingen